Results
1 -
8 of
8
(Click
here to explore results)
- Drug Repurposing, Chapter 10 Preclinical. A Repurposed Novel Lyn Kinase Activator, MLR-1023, is a Model Example of Pharmacological Pleiotropy. Andrew G. Reaume, Christopher A. Lipinski
, 2022
, Pages 196-220
- Phenotypic Drug Discovery, Chapter 12 Why an In Vivo Screening Platform Covering Broad Therapeutic Spectrum is an Ideal Tool for Drug Repositioning: Illustrated by Discovery of a Novel Class of Insulin Sensitizers. Andrew G. Reaume, Christopher A. Lipinski
, 2021
, Pages 217-232
- Drug Repurposing, Subject Index
, 2022
, Pages 320-331
- Drug Repurposing, Contents
, 2022
, Pages P011-P018
- Kinase Drug Discovery: Modern Approaches, CHAPTER 14 The Future of Kinase Therapeutics. Brion Murray, Matthew M. Hayward, Ravi G. Kurumbail
, 2019
, Pages 381-405
- Phenotypic Drug Discovery, Subject Index
, 2021
, Pages 242-245
- Phenotypic Drug Discovery, Contents
, 2021
, Pages P021-P026
- Drug Repurposing, Chapter 1 Introduction and Historical Overview of Drug Repurposing Opportunities. S. Pushpakom
, 2022
, Pages 1-13